Quest Diagnostics (DGX) Consolidated Net Income (2009 - 2026)

Quest Diagnostics has disclosed Consolidated Net Income across 14 years of filings, most recently posting $260.0 million for Q1 2026.

• Consolidated Net Income for Q1 2026 came in at $260.0 million, up 19.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 13.93% YoY), and the FY2025 annual result was $1.0 billion, up 11.31% from the prior year.
• Consolidated Net Income came in at $260.0 million for Q1 2026 at Quest Diagnostics, up from $249.0 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $342.0 million in Q1 2022 to a low of $113.0 million in Q4 2022.
• The 5-year median for Consolidated Net Income is $240.0 million (2024), against an average of $236.4 million.
• Across the five-year window, Consolidated Net Income slumped 70.88% in 2022 and soared 74.34% in 2023, its largest moves.
• Quest Diagnostics' Consolidated Net Income stood at $113.0 million in 2022, then jumped by 74.34% to $197.0 million in 2023, then gained by 17.26% to $231.0 million in 2024, then rose by 7.79% to $249.0 million in 2025, then grew by 4.42% to $260.0 million in 2026.
• The last three Consolidated Net Income figures came in at $260.0 million (Q1 2026), $249.0 million (Q4 2025), and $251.0 million (Q3 2025), per Business Quant data.